[1]
S. Jovičić, V. Gajanin, and S. Umičević Šipka, “Cutaneous side effects during therapy with erlotinib - case report: Erlotinib case report”, Scr Med, vol. 52, no. 4, pp. 317–320, Dec. 2021, doi: 10.5937/scriptamed52-35385.